Last reviewed · How we verify
NCT06906913: Oral Anal HPV
Oral and Anal Swab Sampling in Patients With HPV Positivity
trial testing HPV testing in HPV in 30 participants. Completed in 19 November 2024.
31 July 2024
Quick facts
| Lead sponsor | Medipol University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 14 March 2023 |
| Primary completion | 31 July 2024 |
| Estimated completion | 19 November 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- HPV testing
Conditions studied
- HPV — all drugs for HPV →
Sponsor
Medipol University
Who can join
Adults 18 to 50, female only, with HPV. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients whose pathology results are reported as cervical intraepithelial neoplasia (CIN) 1, CIN 2, and CIN 3, are recruited. We aimed to evaluate HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3, by collecting oropharyngeal and anal swab samples. A total of 30 women of reproductive age, who consented to participate, were included in the study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Multi-site HPV infection in women with cervical intraepithelial neoplasia: an exploratory analysis.
Akçaoğlu T, Soykan Y, Bayramoğlu Tepe N, Doğan O. · · 2025 · PMID 40965375 · DOI 10.4274/jtgga.galenos.2025.2025-3-10
Verify or expand the search:
- PubMed search for NCT06906913
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of HPV testing
Trials testing the same drug.
- NCT06796738 — Advancing Cervical Cancer Screening Through the Emergency Department - IIS · NA · active not recruiting
- NCT05173324 — Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial · Phase 3 · not yet recruiting
- NCT05133661 — SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study) · active not recruiting
- NCT05229679 — HPV-based Screening Among Women 23-29 Years of Age · NA · recruiting
- NCT04154358 — Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men · NA · unknown
Other recruiting trials for HPV
Currently open trials in the same condition.
- NCT07493928 — HPV After chemoRadioTherapy · recruiting
- NCT07065630 — Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer · Phase 2 · recruiting
- NCT06796738 — Advancing Cervical Cancer Screening Through the Emergency Department - IIS · NA · active not recruiting
- NCT07273383 — Self-sampling for HPV Screening · NA · active not recruiting
- NCT07438080 — Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Ri · NA · recruiting
Other Medipol University trials
Trials by the same sponsor.
- NCT07277803 — Device-Based vs Manual Sensory Training in Low Back Pain · NA · not yet recruiting
- NCT07214636 — Development and Investigation of the ApneaTheraPlay · NA · not yet recruiting
- NCT07534475 — Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT · NA · not yet recruiting
- NCT07534488 — Sacral Erector Spinae Plane Block in Pilonidal Sinus Surgery · NA · not yet recruiting
- NCT07525648 — Comparison of the Effects of Sevoflurane and Desflurane on Optic Nerve Sheath Diameter During Laparoscopic Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06906913 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medipol University
- Last refreshed: 2 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06906913.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing